MicroRNA1385p regulates neural stem cell proliferation and differentiation in vitro by targeting TRIP6 expression

Juan Wang1, Jixia Li2, Jian Yang3

  • 1Stem Cell Center, East Hospital, Tongji University School of Medicine, Shanghai 200120, P.R. China.

Molecular Medicine Reports
|September 26, 2017
PubMed

Insights

MicroRNA-138-5p (miR-138-5p) is crucial for neural stem cell (NSC) development. Lowering miR-138-5p promotes NSC proliferation and inhibits differentiation, impacting potential neurological disorder treatments.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Stem Cell Research

Background:

  • MicroRNAs (miRNAs) are key regulators of neural stem cell (NSC) proliferation and differentiation.
  • Understanding miRNA roles is vital for developing treatments for neurological disorders.

Purpose of the Study:

  • To investigate the role of microRNA (miR)-138-5p in regulating neural stem cell (NSC) proliferation and differentiation.
  • To identify the molecular targets and mechanisms through which miR-138-5p exerts its effects on NSCs.

Main Methods:

  • Quantitative-polymerase chain reaction (qPCR) to measure miR-138-5p expression during NSC differentiation.
  • Transfection with miR-138-5p mimics and inhibitors to manipulate its levels in NSCs.
  • Luciferase reporter assays to confirm direct binding of miR-138-5p to its target mRNA.
  • Overexpression and knockdown of the target gene, thyroid hormone receptor interacting protein 6 (TRIP6), to assess its interaction with miR-138-5p effects.

Main Results:

  • miR-138-5p expression decreased during in vitro neural differentiation of NSCs.
  • Overexpression of miR-138-5p inhibited NSC proliferation and promoted differentiation.
  • Suppression of miR-138-5p enhanced NSC proliferation and attenuated differentiation.
  • TRIP6 was identified as a direct target of miR-138-5p, with its expression negatively correlated to miR-138-5p levels.
  • Modulation of TRIP6 expression rescued or mimicked the effects of miR-138-5p on NSC proliferation and differentiation.

Conclusions:

  • miR-138-5p acts as a negative regulator of NSC proliferation and a positive regulator of NSC differentiation.
  • The miR-138-5p/TRIP6 axis is a critical pathway controlling NSC fate.
  • Targeting miR-138-5p in NSCs offers a potential therapeutic strategy for neurological disorders.